Royalty Pharma CFO reports gift and share award
Royalty Pharma plc EVP & CFO Terrance P. Coyne reported two equity changes.
Rhea-AI Filing Summary
Royalty Pharma plc EVP & CFO Terrance P. Coyne reported two equity changes. On August 5, 2026, an exempt acquisition under Rule 16b-3 delivered 11,002 Class A Ordinary Shares through settlement of Equity Performance Awards to TPC RP EPA1 LLC. On August 7, 2026, an indirect bona fide gift transferred 18,500 Class E Ordinary Shares, leaving 1,788,777 Class E shares indirectly held; these Class E shares are subject to vesting and are ultimately convertible into Class A Ordinary Shares. Coyne and related vehicles also hold limited partnership interests exchangeable into 6,448,180 Class A Ordinary Shares, plus additional direct and indirect Class A positions.
Positive
- None.
Negative
- None.
Insider Trade Summary
18,500 shares gifted
Gift
6 txns
Insider
Coyne Terrance P.
Role
EVP & CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Class E Ordinary Shares F2 | 18,500 | $0.00 | $0.00 |
| Grant/Award | Class A Ordinary Shares F1 | 11,002 | $0.00 | $0.00 |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Class E Ordinary Shares — 1,788,777 contracts (Indirect, See Footnote (2));
Class A Ordinary Shares — 11,002 shares (Indirect, TPC RP EPA1 LLC);
Class A Ordinary Shares — 24,170 shares (Indirect, By Spouse's IRA);
Class A Ordinary Shares — 23,270 shares (Indirect, By IRA);
Class A Ordinary Shares — 1,500 shares (Direct);
Class A Ordinary Shares — 1,450 shares (Indirect, By Spouse)
Footnotes (2)
- F1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
- F2. No Class E Ordinary Shares of RPH ("Class E Shares") are being converted by the Reporting Person. Class E Shares are subject to vesting conditions. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.
Key Figures
Equity award shares: 11,002 Class A Ordinary Shares
Gifted Class E shares: 18,500 Class E Ordinary Shares
Class E shares remaining: 1,788,777 Class E Ordinary Shares
+2 more
5 metrics
Equity award shares
11,002 Class A Ordinary Shares
Exempt acquisition in settlement of Equity Performance Awards on August 5, 2026
Gifted Class E shares
18,500 Class E Ordinary Shares
Bona fide gift of derivative interests on August 7, 2026
Class E shares remaining
1,788,777 Class E Ordinary Shares
Indirect Class E holdings after the reported bona fide gift
Exchangeable LP interests
6,448,180 Class A Ordinary Shares
Limited partnership interests exchangeable into Class A shares held by Coyne and family vehicles
Spouse's IRA Class A holdings
24,170 Class A Ordinary Shares
Indirect Class A holdings by spouse's IRA as of August 5, 2026
Key Terms
bona fide gift, Rule 16b-3, Equity Performance Awards, Class E Ordinary Shares, +1 more
5 terms
bona fide gift financial
"transaction_code_description": "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Rule 16b-3 financial
"Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Equity Performance Awards financial
"in connection with the settlement of Equity Performance Awards."
limited partnership interests financial
"hold limited partnership interests in RPI US Partners 2019, LP exchangeable"
An ownership stake in a limited partnership gives an investor the role of a limited partner who provides capital but does not run day-to-day operations; a separate general partner manages the business. It matters because limited partners share profits, losses, and tax benefits but generally cannot lose more than they invested and have little control or liquidity—think of it like quietly funding a small business while someone else manages it, with potential return and risk tied to the venture’s performance.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider equity transactions did Royalty Pharma (RPRX) CFO Terrance P. Coyne report?
Terrance P. Coyne reported an exempt acquisition of 11,002 Class A Ordinary Shares and an indirect bona fide gift of 18,500 Class E Ordinary Shares. The acquisition settled Equity Performance Awards, while the gift reduced but did not eliminate his indirect Class E holdings.
What was the size of Terrance P. Coyne’s bona fide gift reported at RPRX?
The filing reports a bona fide gift of 18,500 Class E Ordinary Shares as a derivative transaction. After this August 7, 2026 gift, Coyne continued to indirectly hold 1,788,777 Class E shares that are subject to vesting and later conversion rights.
What additional Royalty Pharma (RPRX) exposure do Coyne and his family vehicles have?
Coyne and family vehicles hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 6,448,180 Class A Ordinary Shares. They also report several direct and indirect Class A holdings, including IRA and spouse IRA accounts, alongside the equity award settlement shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
